Tech Company Financing Transactions
Microsure Funding Round
On 10/4/2023, Microsure landed $40.1 million in Series B investment from BOM, Eindhoven University of Technology (TU/e) and European Innovation Council Fund.
Transaction Overview
Company Name
Announced On
10/4/2023
Transaction Type
Venture Equity
Amount
$40,095,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to finalize the development of its newest microsurgical robot MUSA-3 for clinical studies, followed by FDA clearance in the USA and CE-mark in Europe.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Science Park Eindhoven 5080
Son, 5692 EA
NL
Son, 5692 EA
NL
Phone
Undisclosed
Website
Email Address
Overview
Developer of a robotic assistance device designed to optimize microsurgical performance. The company's medical device allows for a hybrid microsurgical procedure that scales down motion seamlessly and filters out tremors to keep a steady hand at any time throughout every microsurgical procedure, enabling surgeons to perform surgeries with increased precision and micro-surgeons to use their own micro-instruments, for a low CoO for the hospital.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sjaak Deckers
Chief Technical Officer
Dick Dijkkamp
Co-Founder
Tom Mulken
Browse more venture capital transactions:
Prev: 10/4/2023: Everise venture capital transaction
Next: 10/4/2023: Saidot venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC transactions on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs